Sign Up Today and Learn More About Iantrek Stock
Invest in or calculate the value of your shares in Iantrek or other pre-IPO companies through EquityZen's platform.
Iantrek Stock (IANT)
Iantrek develops technology for minimally invasive microinvasive glaucoma surgery.
About Iantrek Stock
Founded
2019
Headquarters
White Plains, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Iantrek Press Mentions
Stay in the know about the latest news on Iantrek
Iantrek raises $42M for Alloflo Uveo glaucoma therapy launch
bioworld • Aug 30, 2025
Iantrek: $42 Million Series C Raised For Interventional Glaucoma Therapy
pulse2 • Aug 23, 2025
Iantrek Raises $42M in Series C for Glaucoma Treatment Device
mpo-mag • Aug 23, 2025
Iantrek sees $42M fundraising for alternative glaucoma surgery launch
fiercebiotech • Aug 21, 2025
Iantrek Raises $42 Million Series C
vcnewsdaily • Aug 21, 2025
Iantrek Management
Leadership team at Iantrek
Board Member
Farrell Tyson
Board Member
Marc Andre Marcotte
Join now and verify your accreditation status to gain access to:
- Iantrek Current Valuation
- Iantrek Stock Price
- Iantrek Management
- Available deals in Iantrek and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Iantrek Cap Table and Funding History by Share Class and Liquidity Preferences
- Iantrek Revenue and Financials
- Iantrek Highlights
- Iantrek Business Model
- Iantrek Risk Factors
- Iantrek Research Report from SACRA Research
Trading Iantrek Stock
How to invest in Iantrek stock?
Accredited investors can buy pre-IPO stock in companies like Iantrek through EquityZen funds. These investments are made available by existing Iantrek shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Iantrek stock?
Shareholders can sell their Iantrek stock through EquityZen's private company marketplace. EquityZen's network includes over 390K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 48K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
